NCT04267822 Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV Status WITHDRAWN Phase PHASE2
NCT04267614 This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients. Status COMPLETED Phase N/A
NCT04267380 A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day Status COMPLETED Phase N/A
NCT04267250 Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids Status COMPLETED Phase PHASE1
NCT04266509 Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600 Status COMPLETED Phase PHASE1
NCT04258995 A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS Status COMPLETED Phase PHASE2
NCT04258943 Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04255875 Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT04254172 A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy Status TERMINATED Phase N/A
NCT04253353 A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics Status COMPLETED Phase PHASE1
NCT04247594 Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD Status TERMINATED Phase PHASE2
NCT04239521 The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata Status COMPLETED Phase N/A
NCT04237792 Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans Status COMPLETED Phase PHASE4
NCT04234698 Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia Status COMPLETED Phase N/A
NCT04231851 CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04230213 A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3